SUMMARY
We present a rare case of long-term alcoholic liver disease that progressed from alcoholic liver fibrosis to alcoholic liver cirrhosis, and following passive abstinence, the patient's condition then improved to alcoholic liver fibrosis. A 70-year-old Japanese man who had consumed large amounts of alcohol since he was 20 years old received a liver biopsy for evaluation of liver dysfunction at the age of 48 in 1991. The biopsy indicated alcoholic liver fibrosis, stage 2. Eight years later, a second biopsy indicated alcoholic liver cirrhosis. The patient continued to drink until a cerebral haemorrhage in 2000 led to left hemiparesis. Thereafter, he had to accept passive abstinence. He then received follow-up liver biopsies in 2001 and 2002, both of which indicated improvement of the fibrosis.
BACKGROUND
Alcohol still accounts for a substantial proportion of liver cirrhosis cases. Some patients with alcoholic liver disease (ALD) progress to alcoholic liver cirrhosis (AL-LC) through alcoholic fatty liver (AFL) and alcoholic liver fibrosis (ALF). It is difficult for doctors and researchers to follow-up patients with ALD for long periods because of the characteristics of the patients. For a large proportion of patients with ALD, the disease state generally worsens because they decide to quit going to the hospital or continue to drink despite their hospital visit. Moreover, most of the patients with ALD can hardly abstain from drinking even if they develop AL-LC.
To our knowledge, no report on patients with ALD has confirmed development from ALF to AL-LC and improvement to ALF again by consecutive liver biopsy over a long period. We had the rare opportunity for extended observation of a patient with ALD who had progressed from ALF to AL-LC, and following passive abstinence due to cerebral haemorrhage, his condition then improved to ALF after extensive follow-up. Our observations are presented.
CASE PRESENTATION
The patient was a 70-year-old Japanese man with no history of blood transfusion. He had suffered from ALD since 1963 (at the age of 25), alcoholic chronic pancreatitis since 1991 (at the age of 48), liver cirrhosis with hepatic encephalopathy since 1999 (at the age of 56) and diabetes mellitus since 2000 (at the age of 57). In this period HBs antigen, second-generation anti-hepatitis C virus (HCV) antibody, HCV RNA, antinuclear, antibody, antismooth muscle antibody, liver kidney microsomal antibody 1 and antimitochondrial antibody were all negative. Wilson's disease and primary haemochromatosis was excluded. He underwent endoscopic mucosal resection (EMR) for early gastric cancer in 1997 and 1999 (at the ages of 54 and 56) and cerebral haemorrhage in 2000 (at the age of 57).
He consumed alcohol for more than 37 years, from the age of 20 (in 1963) to 57 (in 2000) (total ethanol consumption: approximately 2900 kg; 210 g/day). In 1991, he had undergone liver biopsy for the first time and was diagnosed with ALF 2-3 ( figure 1A,B) . After 8 years, he underwent a second liver biopsy and was diagnosed with AL-LC (ALF 4) with splenomegaly and collateral vessels and without esophagogastric varices and ascites ( figure 1C,D) . Despite the emergence of severe ALD, he continued to drink after discharge against medical advice. However, in 2000, he was forced to abstain from drinking because of a cerebral haemorrhage. Then, in 2001, he underwent a third liver biopsy and was diagnosed with ALF 3 (figure 1E,F). The following year, he underwent a fourth liver biopsy and was diagnosed with ALF 2 (figure 1G,H). Although he was transferred to our affiliated hospital, he came back to receive endoscopic submucosal dissection for early gastric cancer in 2012. And as of 2013, we confirm he is still living, although he has not desired further liver biopsies as a result of advanced age. The patient's clinical course and sequential laboratory data are shown in figure 2 and table 1, respectively.
OUTCOME AND FOLLOW-UP
Although he was transferred to our affiliated hospital, he came back to receive endoscopic submucosal dissection for early gastric cancer in 2012. As of 2013, we confirm he is still living, although he has refused further liver biopsies as a result of advanced age.
DISCUSSION
Hepatic stellate cells (HSCs) are said to play an important role in the progress of fibrosis and alcoholic metabolism.
1 Acetaldehyde contributes to the direct activation of HSCs. The addition of acetaldehyde to HSCs has been shown to increase the expression of transforming growth factor-β1 (TGF-β1) and the production of type I collagen. 2 3 Furthermore, activated Kupffer cells contribute to progression of fibrosis by initiating the production of cytokines such as TGF-β1, followed by the activation of HSCs. Acetaldehyde has also been reported to directly activate Kupffer cells. . (E) Third biopsy. P-P and P-C bridging fibrosis are present, but fibrotic changes are improved compared with second biopsied specimen. Perivenular and pericellular fibrosis are also present with a few necroinflammatory changes in the lobules. These histological findings correspond to alcoholic fibrosis, severe (ALF3). The fibrosis observed in the third biopsy is much improved from the second biopsy due to passive abstinence (Silver impregnation, ×4). (F) Third biopsy. Mononuclear cells are mildly infiltrated into the portal areas (H&E stain; ×10). (G) Fourth biopsy. P-P and P-C bridging fibrosis are still seen, but apparently decreased fibrotic changes, lacking of macrovesicular steatosis and pericellular fibrosis. There are focal satellite fibrosis and perivenular fibrosis. There is very mild fibrotic expansion in the portal area. The findings correspond to alcoholic liver fibrosis, moderate (ALF2) (Silver impregnation, ×4). (F) Fourth biopsy. Mononuclear cells are scattered in the portal areas with thin fibrotic expansions. Little necroinflammatory changes and fatty change in the parenchymas (H&E stain; ×10).
Hepatocyte apoptosis by death receptors, hepatic inflammation and fibrosis are prominent features of liver diseases. The apoptosis of hepatocyte is important in the progress of liver fibrosis. 6 The apoptosis of hepatocyte induces inflammation. HSCs are activated by the apoptosis of hepatocyte. They reported a model of cholestatic liver injury where Kupffer cell engulfment of apoptotic bodies promotes inflammation and fibrogenesis. 7 Excessive alcohol intake generates oxidative stress in hepatocytes; the oxidative stress then leads to liver fibrosis through the activation of HSCs. Niteo et al 8 reported that the addition of malondialdehyde and 4-hydroxynonenal, two oxidative stress metabolites, upregulated the production of collagen through the activation of HSCs.
The activation of Kupffer cells is suspected to be involved in the progression of fibrosis in ALD. 9 Enomoto et al 10 reported that this mechanism for the progression of fibrosis is associated with an enhancement of the expression of lipopolysaccharidebinding protein.
Natural killer cells induce apoptosis of activated HSCs and restrain the progression of liver fibrosis. 11 12 However, natural killer cells become non-functional in patients with ALD. 13 Hepatic fibrosis is thought to develop in patients with ALD by these mechanisms.
ALD and viral hepatitis result in very different patterns of fibrosis. In viral hepatitis, inflammation is more severe around the portal tract than in other areas. This results in the development of periportal fibrosis. In ALD, by contrast, inflammation is severe around the hepatic vein, leading to perivenular and pericellular fibrosis. Moreover, in viral hepatitis, fibrosis is thought to arise as a repair process against loss of hepatocytes. In ALD, fibrosis primarily results from the direct effect of acetaldehyde. As aforementioned, acetaldehyde in the sinusoid promotes progression of fibrosis by activating HSCs. 2 3 In chronic hepatitis C, fibrosis has been reported to improve (by 0.28±0.03 unit/ year) after achievement of sustained virological response.
14 In ALD, by contrast, the great majority of patients are unable to abstain from alcohol entirely and their liver diseases gradually get worse. Moreover, it is difficult to observe patients with ALD over a long time period because most of them decide to discontinue regular outpatient visits. Therefore, there are very few reports about the improvement of fibrosis in humans.
Popper et al 15 used light microscopy to examine sequential liver specimens of 18 baboons exposed to alcohol on a nutritionally adequate diet for up to 6 years, as well as specimens from pair-fed controls. Furthermore, they followed up on the baboons 1 or 2 years after the period of alcohol intake. As in our case, they reported reduced fibrosis after passive complete abstinence from alcohol.
We herein report a case of ALD that progressed from ALF to AL-LC, and following a period of passive abstinence due to cerebral haemorrhage, the patient's condition improved to ALF over an extended period. We regard our case as fairly rare and valuable because such a case has not been previously reported in the literature. We conclude from our observations that abstinence may lead to improvement of fibrosis in cases of initial LC in a relatively short period without complete reconstruction of the hepatic lobule and vessel. Learning points ▸ For many reasons, it is difficult to follow-up patients with alcoholic liver disease for long periods. ▸ The great majority of patients with alcoholic liver disease (ALD) are unable to abstain from alcohol entirely, and their liver diseases gradually get worse. ▸ To our knowledge, no report on patients with ALD has confirmed development from alcoholic fatty liver (ALF) to alcoholic liver cirrhosis and improvement to ALF again by consecutive liver biopsy over a long period. ▸ Our observations suggest that abstinence may lead to improvement of fibrosis in cases of initial liver cirrhosis in a relatively short period without complete reconstruction of the hepatic lobule and vessel. 
